You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CDR-sb

Showing 1 - 25 of 553
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mild Cognitive Impairment, Prodromal Alzheimer's Disease Trial (AGB101, Placebo)

Not yet recruiting
  • Mild Cognitive Impairment
  • Prodromal Alzheimer's Disease
  • (no location specified)
Aug 3, 2023

Alzheimer's Disease Trial in United States (Aducanumab, Placebo)

Recruiting
  • Alzheimer's Disease
  • Santa Ana, California
  • +19 more
Aug 9, 2022

Clinical Dementia Rating Medical Record

Recruiting
  • Clinical Dementia Rating (CDR) From the Analysis of Medical Record
  • Clinical Dementia Rating (CDR) Face-to-face Interview With the Patient
  • CDR assessment face-to-face
  • Villeurbanne, France
    Hôpital Des Charpennes
Apr 29, 2022

Mild Cognitive Impairment Due to Alzheimer's Disease, Alzheimer's Disease Dementia Trial in Maitland, Spokane (BIIB080,

Recruiting
  • Mild Cognitive Impairment Due to Alzheimer's Disease
  • Alzheimer's Disease Dementia
  • Lady Lake, Florida
  • +5 more
Jan 20, 2023

Alzheimer's Disease Trial in Worldwide (Placebo, Bepranemab)

Recruiting
  • Alzheimer's Disease
  • Placebo
  • Bepranemab
  • Sun City, Arizona
  • +115 more
Aug 18, 2022

Dementia With Lewy Bodies (DLB) Trial in Netherlands, United States (Neflamapimod)

Completed
Has Results
  • Dementia With Lewy Bodies (DLB)
  • La Jolla, California
  • +23 more
Oct 28, 2021

Alzheimer, Early Onset, Mild Cognitive Impairment Trial in Winston-Salem (Dasatinib + Quercetin, Placebo Capsules)

Recruiting
  • Alzheimer Disease, Early Onset
  • Mild Cognitive Impairment
  • Dasatinib + Quercetin
  • Placebo Capsules
  • Winston-Salem, North Carolina
    Wake Forest Health Sciences
Jan 21, 2022

Vascular Dementia, Cognitive Impairment Trial (Tian Ma Bian Chun Zhi Gan Tablets, Placebo)

Recruiting
  • Vascular Dementia
  • Cognitive Impairment
  • Tian Ma Bian Chun Zhi Gan Tablets
  • Placebo
  • Beijing, Beijing, China
    dongzhimmen Hospital, Beijing University of Chinese medicine
Nov 21, 2022

Dementia With Lewy Bodies Trial in Lake Worth (Neflamapimod, Placebo)

Recruiting
  • Dementia With Lewy Bodies
  • Lake Worth, Florida
    JEM Research Institute
May 17, 2023

Vascular Dementia Trial in China (SaiLuoTong capsule, )

Recruiting
  • Vascular Dementia
  • SaiLuoTong capsule
  • placebo
  • Beijing, Beijing, China
  • +30 more
Jan 2, 2023

Alzheimer Trial in Worldwide (neflamapimod, )

Completed
Has Results
  • Alzheimer Disease
  • Long Beach, California
  • +37 more
Sep 28, 2021

Mild Cognitive Impairment Trial in Incheon (ET-101, Sham Device)

Recruiting
  • Mild Cognitive Impairment
  • ET-101
  • Sham Device
  • Incheon, Korea, Republic of
    Gachon University Gil Medical Center
Jul 3, 2023

Alzheimer's Disease Trial in China (50561 high dose, 50561 low dose, Placebo)

Recruiting
  • Alzheimer's Disease
  • 50561 high dose
  • +2 more
  • Beijing, Beijing, China
  • +10 more
Apr 11, 2023

Alzheimer, Memory Complaint, Memory Disorders Trial in Paris (procedure, radiation, biological)

Not yet recruiting
  • Alzheimer Disease
  • +2 more
  • Electroencephalogram (EEG)
  • +6 more
  • Paris, Ile De France, France
    Hôpital Pitié Salpêtrière
Apr 7, 2023

Vascular Dementia Trial in Beijing (TMBCZG, )

Completed
  • Vascular Dementia
  • Beijing, Beijing, China
    Dongzhimen Hospital ,Beijing University of Chinese Medicine
Feb 28, 2021

Alzheimer, Dementia, Brain Diseases Trial in Canada, United States (No Intervention, donanemab)

Active, not recruiting
  • Alzheimer Disease
  • +4 more
  • Phoenix, Arizona
  • +27 more
May 25, 2022

Alzheimer's Disease Trial in Heidelberg, Shepparton, West Perth (SLS-005, Placebo)

Not yet recruiting
  • Alzheimer's Disease
  • Heidelberg, Victoria, Australia
  • +2 more
Dec 23, 2022

Alzheimer Trial (EX039, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • (no location specified)
Jul 7, 2022

Alzheimer's Disease Trial in Worldwide (Semorinemab, Placebo, [18F]GTP1)

Active, not recruiting
Has Results
  • Alzheimer's Disease
  • Garden Grove, California
  • +48 more
Sep 1, 2022

Alzheimer's Disease Trial in United States (Hydroxypropyl Beta Cyclodextrin, Placebo)

Recruiting
  • Alzheimer's Disease
  • Hydroxypropyl Beta Cyclodextrin
  • Placebo
  • Brooksville, Florida
  • +4 more
Nov 22, 2022

Mild Cognitive Impairment, Cognitive Function, Cognitive Decline Trial in Hangzhou (MIND diet education, Routine follow-up and

Recruiting
  • Mild Cognitive Impairment
  • +2 more
  • MIND diet education
  • Routine follow-up and general advice
  • Hangzhou, Zhejiang, China
    Zhejiang University School of Medicine
Aug 3, 2023

Alzheimer's Disease Trial in White Plains (Benfotiamine)

Completed
Has Results
  • Alzheimer's Disease
  • White Plains, New York
    Burke
Jun 2, 2022

Alzheimer Trial in Korea, Republic of (Choline Alfoscerate 400mg, Placebo)

Recruiting
  • Alzheimer Disease
  • Choline Alfoscerate 400mg
  • Placebo
  • Changwon, Korea, Republic of
  • +3 more
May 16, 2022

Moderate Alzheimer's Disease Trial (GV1001, Normal saline)

Withdrawn
  • Moderate Alzheimer's Disease
  • (no location specified)
Feb 15, 2022

Alzheimer Trial (TW001, Placebo)

Not yet recruiting
  • Alzheimer Disease
  • (no location specified)
Apr 11, 2022